Biotinylated synthetic chemokines: Their use for the development of nonradioactive whole-cell binding assays

Journal of Biomolecular Screening

Volumn 8, Issue 3, 2003, Pages 316-323

  Thierry, Anne Christine ^a   Perrenoud, Geneviève ^a   Pinaud, Stéphane ^a   Bigler, Nicolas ^a   Denis, Bérangère ^a   Roggero, Mario ^a   Moulon, Corinne ^a   Demotz, Stéphane ^a  

^a Dictagene   (Switzerland)

Author keywords

CCL22 analogues; CCR4 transfected and untransfected cells; Chemokines; Whole cell binding assays

Indexed keywords

AGAROSE; BIOTIN; CHEMOKINE; CHEMOKINE RECEPTOR; LACTATE DEHYDROGENASE; LIGAND; POLYPEPTIDE; STREPTAVIDIN; BETA CHEMOKINE; CC CHEMOKINE RECEPTOR 4; CCL22 CHEMOKINE; CCR4 PROTEIN, MAMMALIAN; PEPTIDE; SEPHAROSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; ASSAY; BINDING AFFINITY; BIOTINYLATION; CELL MIGRATION; COLORIMETRY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; CELL LINE; CELL MOTION; CELL SEPARATION; CHEMISTRY; DOSE RESPONSE; GENETIC TRANSFECTION; MACROPHAGE; METABOLISM; PROTEIN BINDING; PROTEIN FOLDING; TIME; TUMOR CELL LINE;

BIOTIN; BIOTINYLATION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SEPARATION; CHEMOKINES, CC; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; LIGANDS; MACROPHAGES; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING; RECEPTORS, CHEMOKINE; SEPHAROSE; STREPTAVIDIN; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 1542648886     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087057103008003009     Document Type: Article

References (18)

1. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
2. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
3. Horuk R: Chemokine receptors. Cyt Growth Fact Rev 2001;12:313-335.
4. Fernandez EJ, Lolis E: Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 2002;42:469-499.
5. Proudfoot AEI: Chemokine receptors: multifaceted therapeutic targets. Nature Reviews Immunol 2002;2:106-115.
6. Hayes IM, Jordan NJ, Towers S, Smith G, Paterson JR, Earnshaw JJ, et al: Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol 1998;18:397-403.
7. Andjelkovic AV, Spencer DD, Pachter JS: Visualization of chemokine binding sites on human brain microvessels. J Cell Biol 1999;145:403-412.
8. Zhu L, Bisgaier CL, Aviram M, Newton RS: 9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells. Arterioscler Thromb Vasc Biol 1999;19:2105-2111.
9. Yoshimura T, Leonard EJ: Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 1990;145:292-297.
10. Sato H, Hayashi E, Yamada N, Yatagai M, Takahara Y: Further studies on the site-specific protein modification by microbial transglutaminase. Bioconjug Chem 2001;12:701-710.
11. Luster AD: Antichemokine immunotherapy for allergic diseases. Curr Opin Allergy Clin Immunol 2001;1:561-567.
12. Romagnani S: Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885.
13. Roggero MA, Meraldi V, Lopez JA, Eberl G, Romero JC, Matile H, et al: The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response. Eur J Immunol 2000;30:2679-2685.
14. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, et al: The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 2001;276:2986-2991.
15. Hemmerich S, Paavola C, Bloom A, Bhakta S, Freedman R, Grunberger D, et al: Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 1999;38:13013-13025.
16. Jarnagin K, Grunberger D, Mulkins M, Wong B, Hemmerich S, Paavola C, et al: Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry 1999;38: 16167-16177.
17. Struyf S, Proost P, Sozzani S, Mantovani A, Wuyts A, De Clercq E, et al: Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J Immunol 1998;161:2672-2675.
18. Proost P, Menten P, Struyf S, Schutyser E, De Meester I, Van Damme J: Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 2000;96:1674-1680.